Activators for the synthesis of nucleic acid pharmaceuticals
Patented BMI Activator
The Honeywell BMI activator for nucleic acid drug synthesis is patented and features a unique formulation. It is an excellent activator that does not precipitate even at low temperatures, allowing for the transportation, storage, and handling of the activator during winter. This is a proposal for cost reduction associated with the production of nucleic acid drugs.
- Company：林純薬工業 試薬化成品営業部
- Price：Other
